Thirteenth National Congress of the Italian Association of Ophthalmologists (AIMO), the first organized together with the Italian Society of Ophthalmological Sciences (SISO). The contents of the congress event reflect the specific missions of the two organizations and include the innovations and techniques performed live that can improve daily clinical and surgical activities together with academic formats and communications on new research projects.

Congress of SIOT orthopedics, in a scientific and healthcare context characterized by great transformations. Robotics, virtual reality, computer aided tools, gender medicine, female professional specificities, holistic approach to orthopedics. These are some of the themes that represent the changes taking place, in medicine and in the specialty, that orthopedic surgeons are called to face, with the support of their own scientific society.

The international congress of aesthetic medicine, in its twenty-fourth edition, confirms - both in the trends of the demand for services and in the offer - the increasingly close intertwining between beauty and well-being, a combination represented by the search for protocols attentive to prevention and based on minimal invasiveness . Among the most interesting innovations, biostimulation techniques and synergies between devices and active ingredients that make treatments more effective.

ESHRE’s 38th Annual Meeting took place from 3 to 6 July 2022 in Milan, Italy. This year, the Congress of the European Society of Human Reproduction and Embriology was organised as a hybrid event with almost 10 thousand participants for the main programme from 128 different countries. The main program features the most stimulating hot topics of gynecological endocrinology and reproductive medicine.

The 96th National Congress of the Italian Society of Medical, Surgical, Aesthetic Dermatology and Sexually Transmitted Diseases - SIDeMaST took place at the MiCo in Milan, in attendance, after two online editions. In parallel with the congress activity, the event offered an intense training program for specialists and postgraduates.

Heart Rhythm 2022, held in San Francisco, California, is considered the most anticipated global EP event of the year. Dedicated to advancing the science of cardiac pacing and electrophysiology, it has seen the participation of over 7,700 heart rhythm professionals from around the world. For the first time in San Francisco, an abundance of new disciplines and technologies destined to change clinical practice have been unveiled.

The first national congress of the newly established S.I.S.O., a scientific society that represents Italian specialists operating in all areas of ophthalmology, was held at the Europa Congress Center of the Gemelli Hospital. The event was attended by numerous single-issue and regional scientific societies which contributed to the creation of a vast program that draws on the various subspecialties of ophthalmology with 47 single-issue courses and 32 live surgeries.

Among the main topics of the 2022 edition of the OCT & RETINA Forum is the integration of new technologies with the treatments available in clinical practice, not only for research purposes but mainly because they are crucial for the diagnosis of retinal diseases and therapy. The congress program includes presentations on imaging, focus on therapies, updates on the treatments of maculopathies, of vascular and retinal diseases. Some of the most important researchers present the results of the latest trials.

The 2022 edition of Scilla Cuore proposes for the 22nd time a widely tested formula that sees numerous key leaders of Italian cardiology and related disciplines as protagonists in the dual function of providing professional updating and engaging scientific comparison on the hottest topics of clinical practice and research. The scientific program offers a wide range of widely debated topics, from female specificity in cardiovascular disease to news on heart failure and arrhythmias.

Nuove tecnologie e imaging digitale in sala operatoria, sfida impegnativa per la neurochirurgia italiana

Con il congresso in presenza torna il confronto sugli "hot topics" della cardiologia per mettere in connessione ricerca e pratica clinica

La nuova formula congressuale ibrida su base europea, per focalizzare i temi caldi della cardiologia interventistica

Advances in the knowledge and treatment of lymphoma at  ICML 2021 virtual edition

Nel segno della complessità gestionale e dell'innovazione terapeutica

The 33rd Congress of the European Society of Cardiology took place in digital form attracting over one hundred thousand participants

Cutting edge issues concerning the diagnosis, therapy and management of the patient suffering from IBD

An educational meeting dedicated to sarcomas and GIST to improve diagnostic and therapeutic quality

The Congress focused on results related to numerous new therapies, both for inflammatory diseases and cutaneous tumors

The world's leading forum on both basic and clinical research for the sixth most common cancer pathology

Authoritative studies hypothesize that, in 2050, 50% of the world's population could be nearsighted. D.I.M.S. optical technologies (Defocus Incorporated Multiple Segments) have been developed to counteract myopic progression, occurring on all continents, caused by various factors but above all by incorrect lifestyles. The positive confirmations regarding the clinical use of this technology, coming from studies lasting over two years, are the subject of the debate, tooking place in the recent edition of the MIDO Eyewear Show, which we propose below.

Female intimate health is the subject of this multidisciplinary round table and is a topic that involves a large portion of the population, affecting people's emotional state, social relationships and sexual activity. Over ten years of studies on the treatment of genitourinary syndrome with CO2 laser technology confirm the validity of the method applied. From the clinical and technological know-how of this experience, further challenges are now born, based on new advanced devices, with the aim of providing the medical profession with a multimodal "package" to deal with many of the pathological manifestations related to the urogenital system.

25 yeras of studies on the mitochondria have allowed a group of biomolecular researchers from the University of Catania to identify and test a peptide capable of restoring mitochondrial function, counteracting the action of toxic proteins which - particularly in neurodegenerative diseases – limit the role of the VDAC protein. A spin-off of the Sicilian university has patented the discovery and is conducting studies on animal models. In the meantime, the search for an industrial partner has begun.

Focus on myasthenia gravis and neuromyelitis optica, two rare autoimmune neurological diseases sharing a pathogenetic mechanism involving the complement system. The protagonist of the 4 video interviews carried out on the occasion of the 52nd Congress of the Italian Society of Neurology is the monoclonal antibody Eculizumab which bases its efficacy on the inhibition of the complement and on the rapidity of the therapeutic response. Among the topics addressed, the comparison between new therapies and traditional treatments, diagnostic difficulties, drug resistance and side effects.

Press conference to present Lipobank, the first European company to offer a complete processing, cryopreservation and thawing service of autologous adipose tissue, rich in mesenchymal stem cells. Lipobank is a partner of the Skin Bank, based in Emilia-Romagna Region, the largest Italian public bank accredited for tissue cryopreservation. A virtuous example of public-private collaboration. Here interviewed clinicians provide a significant picture of the possible uses of this new opportunity.

Insights about the ways to perform radical bladder cancer surgery. At the center of the comparison, the state of health of the "Paduan Ileal Bladder", a method of reconstruction of the urinary organ that uses a portion of the intestine.

Presentation event of the #ShareThesolution manifesto, created with the patronage of Amici Onlus, the National Association for Chronic Inflammatory Diseases of the Atestine and Siccr, the Italian Society of Col-Rettal Surgery and with the non-conditioned contribution of Takeda Italia. The initiative was an opportunity to take stock of the latest therapeutic innovations and current prospects for the attention to the complications of Crohn's disease.

A few months after the conclusion of the Selene HF study, the 18th AIAC Congress offered the opportunity for a comparison of clinical experiences regarding the use of the HeartInsight score in the remote management of heart failure. The protagonists are some of the clinicians who participated in the study, carried out on a panel of over a thousand patients. Given the complexity of the decision-making processes concerning heart failure, the expectations that emerge from the interviews regarding the first uses of the algorithm in the field suggest the stage of a path that leads to Artificial Intelligence.

Two innovations concerning the treatment of serious neuromuscular diseases (Amyotrophic Lateral Sclerosis and Duchenne Muscular Dystrophy) are presented by the Chief Medical Officer of the Italfarmaco Group, Paolo Bettica. The event offers the opportunity for the Group CEO, Paolo Zambonardi, to underline that these two results are the effect of a flexible and articulated business strategy, based on two sectors of business activity, apparently irreconcilable but in reality synergistic: basic research and “incremental innovation”.

Viscosupplementation: new formulation mimicking the synovial fluid, based on hyaluronic acid and high concentration sodium chondroitin

New surgical techniques and multidisciplinary approach: the commitment of S.I.C.OB. for the quality of care for the obese patient

Dimostrata in laboratorio (e brevettata) l'efficacia della proteina prodotta dalle contrazioni muscolari

Contributo delle Società scientifiche al XXVII Congresso Nazionale CDUO

L'Ospedale Buccheri La Ferla di Palermo guida la "Rete HCV Sicilia" per realizzare l'obiettivo OMS